financetom
Business
financetom
/
Business
/
A.I.S. Resources Renews Focus on Gold Exploration in Australia
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
A.I.S. Resources Renews Focus on Gold Exploration in Australia
Apr 9, 2024 4:18 AM

06:50 AM EDT, 04/09/2024 (MT Newswires) -- A.I.S. Resources ( AISSF ) overnight Monday said that it is renewing its focus on gold exploration in Australia.

Through its wholly-owned Australian subsidiary AIS Resources Aust. Pty, AIS continues to own 100% interest in the 28 square kilometers squared Fosterville-Toolleen Exploration License; 60% interest in the 58 km squared Bright Exploration License, with an option to buy 100%; and 100% interest in the 167 km squared Kingston Exploration License.

The company said previous work has identified "high-potential" drill targets on the Toolleen property, with geological characteristics similar to the neighboring high-grade Fosterville mine.

"The significant increase in gold prices has renewed interest in gold exploration, and the three properties in Australia are ready for immediate on-site work," Andrew Neale, president and CEO of A.I.S., said. "Our major shareholders are indicating their ongoing support for work in this area, and the Company is actively engaged in evaluating opportunities to raise the appropriate funding," The Company will be providing updates in a timely manner as these efforts progress."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved